Document is current

Article History

Received: 17 March 2025

Accepted: 18 March 2025

First Online: 30 May 2025

Declarations

:

: TMM reports Advisory Board from Ability PhaAbility Pharmaceuticals SL, Arcus Bioscience Inc, AstraZeneca, Basilea Pharma, Baxter, BioLineRX Ltd, Celgene, Eisai, Incyte, Ipsen Bioscience Inc, MSD and Novocure rmaceuticals SL; Speaker from Janssen, Lilly, Esteve, Daïchi, Biontech, Novartis, Jazz Pharmaceuticals steve, Daïchi, Biontech, Novartis and Jazz Pharmaceuticals; Grant from MSD, Novocure, QED Therapeutics, Roche Farma, Sanofi-Aventis, Servier and Zymeworks and Other from Servier, AstraZeneca, Sanofi, Incyte, Lilly, MSD and Roche. JAA reports Advisory Board from Servier, Incyte, Taio and AstraZeneca; Speaker from Incyte and AstraZeneca and Other from Merck and Servier. ARC reports Advisory Board from Amgen and Takeda; Speaker from Medtronic and Other from Servier. RAPC reports Advisory Board—Speaker—Other from Servier, Roche and AstraZeneca; Advisory Board from Ipsen; Advisory Board—Speaker from Astellas and Eisai and Speaker from Lilly. TSN reports Speaker from BMS, MSD, AstraZeneca, Astellas and Jazz Pharmaceuticals and Advisory Board from Amgen and Beigene Esp. SLU. MTCO, AMJG, ALL, AMLM, JG have nothing to disclose.

: Compliance with ethical standards. The current study has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: Not applicable.

: Not applicable.